Investigation of reduced susceptibility to glycopeptides among methicillin-resistant Staphylococcus aureus isolates from patients in Ireland and evaluation of agar screening methods for detection of heterogeneously glycopeptide-intermediate S. aureus

Journal of Clinical Microbiology

Volumn 45, Issue 10, 2007, Pages 3263-3269

  Fitzgibbon, Margaret M ^b   Rossney, Angela S ^a   O'Connell, Brian ^b  

^a ST JAMES S HOSPITAL   (Ireland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPEPTIDE; TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; BLOOD CULTURE; CULTURE MEDIUM; IRELAND; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PREVALENCE; PRIORITY JOURNAL;

AGAR; ANTI-BACTERIAL AGENTS; GLYCOPEPTIDES; HUMANS; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCUS AUREUS; TEICOPLANIN; VANCOMYCIN RESISTANCE;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS;

EID: 35348908438     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.00836-07     Document Type: Article

References (30)

1. AB Biodisk. 2004. Etest application sheet 003 staphylococci. AB Biodisk, Ltd., Solna, Sweden. http://www.abbiodisk.com/pdf/eas/M0000143-MH0164. pdf.
2. AB Biodisk. 2004. Etest technical manual: 23 staphylococci. Etest for glycopeptides. AB Biodisk, Ltd., Solna, Sweden. http://www.abbiodisk.com/ pdf/epl/M0000221_MH0271.pdf.
3. Ariza, J., M. Pujol, J. Cabo, C. Pena, N. Fernandez, J. Linares, J. Ayats, and F. Gudiol. 1999. Vancomycin in surgical infections due to methicillin-resistant Staphylococcus aureus with heterogeneous resistance to vancomycin. Lancet 353:1587-1588.
4. Bataineh, H. A. 2006. Resistance of Staphylococcus aureus to vancomycin in Zaqra, Jordan. Pak. J. Med. Sci. 22:144-148.
5. British Society for Antimicrobial Chemotherapy. 2006. BSAC methods for antimicrobial susceptibility testing, version 5, January 2006. BSAC, Birmingham, United Kingdom, www.bsac.org.uk/susceptibility_testing/ bsac_standardized_disc_susceptibility_method.cfm.
6. Brown, D. F., D. I. Edwards, P. M. Hawkey, D. Morrison, G. L. Ridgway, K. J. Towner, and M. W. D. Wren. 2005. Guidelines for the laboratory diagnosis and susceptibility testing of methicillin-resistant Staphylococcus aureus (MRSA). J. Antimicrob. Chemother. 56:1000-1018.
7. Centers for Disease Control and Prevention. 2006. Investigation and control of vancomycin-intermediate and -resistant Staphylococcus aureus (VISA/VRSA). CDC, Atlanta, GA. http://www.cdc.gov/ncidod/dhqp/pdf/ar/ visa_vrsa_guide.pdf. Accessed 14 February 2007.
8. Clinical and Laboratory Standards Institute. 2006. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A7; 7th ed. CLSI, Wayne, PA.
9. Clinical and Laboratory Standards Institute. 2006. Performance standards for antimicrobial susceptibility testing; 16th informational supplement M100-S16. CLSI, Wayne, PA.
10. Comité de l'Antibiogramme de la Société Française de Microbiologie. 2005. Recommendations du CASFM, Communiqué 2005. CASFM, Paris, France. http://www.sfm.asso.fr/nouv/ general.php?pa=5. Accessed 14 February 2007.
11. Department of Health and Children. 2000. North/south study of MRSA in Ireland 1999. Irish Department of Health and Children, Dublin, Ireland. http://www.dohc.ie/publications/pdf/mrsa99.pdf. Accessed 14 February 2007.
12. European Antimicrobial Resistance Surveillance System. 2005. EARSS Manual 2005: EARSS protocol for testing Staphylococcus aureus: new and updated protocols for AST 2005. EARSS RIVM, Bilthoven, The Netherlands. http://www.rivm.nl/earss/tools/. Accessed 14 February 2007.
13. European Committee on Antimicrobial Susceptibility Testing. 2006. Glycopeptides: EUCAST clinical MIC breakpoints 2006-06-20 (v 1.3). EUCAST, Basel, Switzerland. www.srga.org/eucastw/MICTAB/MICglycopeptides.html. Accessed 14 February 2007.
14. Guerin, F., A. Buu-Hoi, J. L. Mainardi, G. Kac, N. Colardelle, S. Vaupre, L. Gutmann, and I. Podglajen. 2000. Outbreak of methicillin- resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in a Parisian hospital. J. Clin. Microbiol. 38:2985-2988.
15. Hiramatsu, K., N. Aritaka, H. Hanaki, S. Kawasaki, Y. Hosoda, S. Hori, Y. Fukuchi, and I. Kobayashi. 1997. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 350:1670-1673.
16. Howden, B. P., P. D. R. Johnson, P. B. Ward, T. P. Stinear, and J. K. Davies. 2006. Isolates with low-level vancomycin resistance associated with persistent methicillin-resistant Staphylococcus aureus bacteremia. Antimicrob. Agents Chemother. 50:3039-3047.
17. Liu, C., and H. F. Chambers. 2003. Staphylococcus aureus with heterogeneous resistance to vancomycin: epidemiology, clinical significance, and critical assessment of diagnostic methods. Antimicrob. Agents Chemother. 47:3040-3045.
18. Nonhoff, C., O. Denis, and M. Struelens. 2005. Low prevalence of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in Belgian hospitals. Clin. Microbiol. Infect. 11:214-220.
19. Park, Y.-J., M. Kim, E.-J. Oh, S.-O. Lee, B. K. Kim, and S. M. Kim. 2000. Screening method for detecting staphylococci with reduced susceptibility to teicoplanin. J. Microbiol. Methods 40:193-198.
20. Rossney, A., M. J. Lawrence, P. M. Morgan, M. M. Fitzgibbon, A. Shore, D. Coleman, C. T. Keane, and B. O'Connell. 2006. Epidemiological typing of MRSA isolates from blood cultures taken in Irish hospitals participating in the European Antimicrobial Resistance Surveillance System (1999-2003). Eur. J. Clin. Microbiol. Infect. Dis. 25:79-89.
21. Rossney, A. S., and C. T. Keane. 2002. Strain variation in the MRSA population over a 10-year period in one Dublin hospital. Eur. J. Clin. Microbiol. Infect. Dis. 21:123-126.
22. Rossney, A. S., P. McDonald, H. Humphreys, G. M. Glynn, and C. T. Keane. 2003. Antimicrobial resistance and epidemiological typing of methicillin-resistant Staphylococcus aureus in Ireland (North and South), 1999. Eur. J. Clin. Microbiol. Infect. Dis. 22:379-381.
23. Sieradzki, K., T. Leski, J. Dick, L. Borio, and A. Tomasz. 2003. Evolution of a vancomycin-intermediate Staphylococcus aureus strain in vivo: multiple changes in the antibiotic resistance phenotypes of a single lineage of methicillin-resistant S. aureus under the impact of antibiotics administered for chemotherapy. J. Clin. Microbiol. 41:1687-1693.
24. Tenover, F. C., M. V. Lancaster, B. C. Hill, C. D. Steward, S. A. Stocker, G. A. Hancock, C. M. O'Hara, N. C. Clark, and K. Hiramatsu. 1998. Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides. J. Clin. Microbiol. 36:1020-1027.
25. Tiwari, H. K., and M. R. Sen. 2006. Emergence of vancomycin resistant Staphylococcus aureus (VRSA) from a tertiary care hospital from northern part of India. Biomed Central, London, United Kingdom. Dis. BMC Infect. http://www.biomedcentral.eom/1471-2334/6/156. Accessed 14 February 2007.
26. Walsh, T. R., A. Bolmstrom, A. Qwarnstrom, P. Ho, M. Wootton, R. A. Howe, A. P. MacGowan, and D. Diekema. 2001. Evaluation of current methods for detection of staphylococci with reduced susceptibility to glycopeptides. J. Clin. Microbiol. 39:2439-2444.
27. Walsh, T. R., and R. A. Howe. 2002. The prevalence and mechanisms of vancomycin resistance in Staphylococcus aureus. Annu. Rev. Microbiol. 56:657-675.
28. Ward, P. B., P. D. Johnson, E. A. Grabsch, B. C. Mayall, and M. L. Grayson. 2001. Treatment failure due to methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to vancomycin. Med. J. Aust. 175:480-483.
29. Wootton, M., R. A. Howe, R. Hillman, T. R. Walsh, P. M. Bennett, and A. P. MacGowan. 2001. A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital. J. Antimicrob. Chemother. 47:399-403.
30. Wootton, M., A. P. MacGowan, T. R. Walsh, and R. A. Howe. 2007. A multi-center study evaluating current strategies for isolating Staphylococcus aureus strains with reduced susceptibility to glycopeptides. J. Clin. Microbiol. 45:329-332.